Accuray (ARAY) Reports Q3 Loss, Lags Revenue Estimates

分组1 - Accuray reported a quarterly loss of $0.06 per share, missing the Zacks Consensus Estimate of a loss of$0.01, and compared to earnings of $0.01 per share a year ago, indicating an earnings surprise of -500$101.13 million, missing the Zacks Consensus Estimate by 11.75%, and down from $118.06 million year-over-year [1] - Accuray has not surpassed consensus EPS estimates over the last four quarters, and has topped consensus revenue estimates only twice in the same period [1] 分组2 - Accuray shares have declined approximately 24.7% since the beginning of the year, contrasting with the S&P 500's gain of 5.6% [2] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [2] - The current consensus EPS estimate for the next quarter is $0.07 on revenues of$137.8 million, and for the current fiscal year, it is -$0.07 on revenues of$463.5 million [4] 分组3 - The Zacks Industry Rank places Medical - Instruments in the bottom 44% of over 250 Zacks industries, indicating potential underperformance compared to the top 50% of ranked industries [4] - The trend of estimate revisions for Accuray is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market [3]